Corpus Christi, TX, United States of America

Robert P Barnes


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Corpus Christi, TX (US) (1986)
  • Frisco, TX (US) (2002 - 2004)

Company Filing History:


Years Active: 1986-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Robert P Barnes

Introduction

Robert P Barnes is a notable inventor based in Corpus Christi, TX (US). He has made significant contributions to the field of cholesterol regulation through his innovative patents. With a total of 3 patents, his work has implications for the diagnosis and treatment of cholesterol-associated disorders.

Latest Patents

Barnes' latest patents include groundbreaking inventions such as ABCG8 vectors, host cells, and methods of making. The first patent provides nucleic acids encoding a novel ABC family cholesterol transporter, ABCG8. These sequences can be utilized for various purposes, including diagnosing and treating cholesterol-related disorders like sitosterolemia. His second patent focuses on drug screening for identifying agents that modulate low-density lipoprotein receptor adaptin-ligand binding. This invention highlights the role of low-density lipoprotein receptor (LDLR) adaptin as a key component in human cholesterol regulation, offering a target for drug design and therapeutic intervention.

Career Highlights

Throughout his career, Robert P Barnes has worked with esteemed institutions, including the University of Texas System. His innovative research has positioned him as a key figure in the field of cholesterol regulation and drug design.

Collaborations

Barnes has collaborated with notable individuals such as Helen H Hobbs and Thomas A Myers, further enhancing the impact of his work in the scientific community.

Conclusion

Robert P Barnes continues to be a significant contributor to the field of cholesterol research through his innovative patents and collaborations. His work not only advances scientific understanding but also holds promise for future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…